In Brief: International Remote Imaging Systems
This article was originally published in The Gray Sheet
Executive Summary
International Remote Imaging Systems: Anticipates late 1996 launch of its White IRIS high-speed leukocyte differential analyzer, IRIS President and CEO Fred Deindoerfer announced at a Jan. 17 session of the American Stock Exchange health care conference in New York City. A 510(k) for the device, which shares 80% of its components with the firm's Yellow IRIS urinalysis workstation, was submitted in July 1995. FDA clearance of the firm's 900UDx urine pathology system, co-developed with Boehringer Mannheim ("The Gray Sheet" Sept. 4, 1995, p. 6), is anticipated by the end of the second quarter...